Aprea Therapeutics, Inc.

APRE·NASDAQ·$0.91Share Price as of 11/2·$6MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/16/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report08/28/26 8-KResults of Operations; Other Events08/12/26 8-KDelisting or Transfer07/23/26 8-KShareholder Vote Results06/17/26 8-KResults of Operations; Other Events05/13/26

Prospectuses and Registrations

424B7Prospectus05/15/26 424B3Prospectus04/29/26 S-3Shelf registration04/22/26 424B3Prospectus03/19/26 S-3/AShelf registration (amended)03/17/26

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 PRE 14APreliminary proxy04/20/26 DEF 14ADefinitive proxy04/22/25 DEFA14AAdditional proxy materials04/22/25

Ownership

SC 13G/ABeneficial ownership (amended)08/13/26 Form 4Insider transaction06/17/26 Form 4Insider transaction06/17/26 Form 4Insider transaction06/17/26 Form 4Insider transaction06/17/26

Other

ARSAnnual report to shareholders04/30/26 EFFECTRequest for effectiveness04/29/26 CORRESPCorrespondence with the SEC04/27/26 UPLOADLetter from the SEC04/27/26 EFFECTRequest for effectiveness03/19/26